GR3030026T3 - Stabilised pharmaceutical compositions containing dobutamine - Google Patents

Stabilised pharmaceutical compositions containing dobutamine

Info

Publication number
GR3030026T3
GR3030026T3 GR990400384T GR990400384T GR3030026T3 GR 3030026 T3 GR3030026 T3 GR 3030026T3 GR 990400384 T GR990400384 T GR 990400384T GR 990400384 T GR990400384 T GR 990400384T GR 3030026 T3 GR3030026 T3 GR 3030026T3
Authority
GR
Greece
Prior art keywords
pharmaceutical compositions
compositions containing
dobutamine
stabilised pharmaceutical
containing dobutamine
Prior art date
Application number
GR990400384T
Other languages
English (en)
Inventor
Daniele Kalifa-Madar
Francois Dietlin
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9483984&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3030026(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of GR3030026T3 publication Critical patent/GR3030026T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
GR990400384T 1995-10-27 1999-04-22 Stabilised pharmaceutical compositions containing dobutamine GR3030026T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9512688A FR2740337B1 (fr) 1995-10-27 1995-10-27 Compositions pharmaceutiques stabilisees contenant un derive ayant une activite adrenergique
PCT/FR1996/001671 WO1997015329A1 (fr) 1995-10-27 1996-10-25 Compositions pharmaceutiques stabilisees contenant de la dobutamine

Publications (1)

Publication Number Publication Date
GR3030026T3 true GR3030026T3 (en) 1999-07-30

Family

ID=9483984

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990400384T GR3030026T3 (en) 1995-10-27 1999-04-22 Stabilised pharmaceutical compositions containing dobutamine

Country Status (11)

Country Link
US (1) US6017966A (el)
EP (1) EP0859635B1 (el)
JP (1) JPH11504344A (el)
AT (1) ATE179075T1 (el)
AU (1) AU7308296A (el)
CA (1) CA2232419A1 (el)
DE (2) DE859635T1 (el)
ES (1) ES2132964T3 (el)
FR (1) FR2740337B1 (el)
GR (1) GR3030026T3 (el)
WO (1) WO1997015329A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19756758C1 (de) * 1997-12-19 1999-08-05 Solvay Pharm Gmbh Stabilisierte pharmazeutische Zusammensetzung enthaltend Dopamin oder Dobutamin
CN112444497A (zh) * 2020-10-23 2021-03-05 马鞍山丰原制药有限公司 一种盐酸多巴酚丁胺含量的检测方法
CN114617844A (zh) * 2022-04-20 2022-06-14 江苏吴中医药集团有限公司 一种盐酸多巴酚丁胺水针注射液的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3808317A (en) * 1969-10-29 1974-04-30 Alcon Labor Inc Stabilized aqueous borate complexes of biologically active catechol amines
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
FR2231377B1 (el) * 1973-05-29 1977-11-04 Barnes Hind Pharm Inc
RO93391B (ro) * 1984-12-20 1988-03-31 Eli Lilly And Company Procedeu pentru prepararea unor saruri de dobutamina
US4980159A (en) * 1989-05-23 1990-12-25 Bristol-Myers Squibb Company Processes and compositions for the topical application of β-adrenergic agonists for pilomotor effects
AU5680994A (en) * 1992-12-10 1994-07-04 Abbott Laboratories Stabilized catecholamine solutions

Also Published As

Publication number Publication date
DE69602208D1 (de) 1999-05-27
FR2740337A1 (fr) 1997-04-30
WO1997015329A1 (fr) 1997-05-01
ATE179075T1 (de) 1999-05-15
AU7308296A (en) 1997-05-15
ES2132964T3 (es) 1999-08-16
US6017966A (en) 2000-01-25
CA2232419A1 (fr) 1997-05-01
FR2740337B1 (fr) 1997-11-21
JPH11504344A (ja) 1999-04-20
EP0859635B1 (fr) 1999-04-21
DE859635T1 (de) 1999-01-07
EP0859635A1 (fr) 1998-08-26
DE69602208T2 (de) 1999-09-02

Similar Documents

Publication Publication Date Title
DK0717617T3 (da) Mikropartikler indeholdende aktive bestanddele og gas
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
DE69319440T2 (de) Herstellung von pharmazeutischen zusammensetzungen, die calcitonin enthalten
FI960849A (fi) Metallikomplekseja sisältäviä farmaseuttisia koostumuksia
MX9202247A (es) Composiciones de globulos recubiertos con medicamentos de baja solubilidad.
FR2696094B1 (fr) Nouvelles compositions pharmaceutiques contenant des cyclosporines.
UA43348C2 (uk) Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад
HK1002017A1 (en) Lyospheres comprising gonadotropin
TW279166B (el)
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
IL141157A0 (en) Salt form of pantoprazole and pharmaceutical compositions containing the same
UA32523C2 (uk) Пептиди, які мають високу біологічну активність, та фармацевтична композиція на їх основі
DE69334146D1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
GR940300095T1 (en) Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient.
GR3030026T3 (en) Stabilised pharmaceutical compositions containing dobutamine
BG103306A (en) Liquid allendronate compositions
EP0638080A4 (en) PYRIMIDINE 7-BISUBSTITUEE-METHYL-4-OXO-3H -, 5H --PYRROLO 3,2-d -], PHARMACEUTICAL USE AND COMPOSITIONS CONTAINING SAID PYRIMIDINE.
EP0630963A3 (en) Acid micro-emulsion.
MA26447A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant
HUT66079A (en) Pharmaceutical compositions containing hirudin as active component
ATE171863T1 (de) Dermato-kosmetologisches präparat
WO2001021140A3 (de) Kosmetische und/oder pharmazeutische zubereitungen
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
BG102904A (en) 1,4-diaryl-2,3-difluoro-2-butene insecticide and acaricidal forms
UA23119A (uk) Психотропhий засіб